Welcome Mattias!
From March 4, Mattias Bergentall joins the MetaboGen team as our new microbiologist. We welcome Mattias and look forward to continuing ou (...) Read the full story
From March 4, Mattias Bergentall joins the MetaboGen team as our new microbiologist. We welcome Mattias and look forward to continuing ou (...) Read the full story
MetaboGen is growing and we are now looking for a Microbiologist and a Project Manager to join our development team. Read more about the (...) Read the full story
BioGaia today announced that its´ subsidiary MetaboGen has reached an important development goal. The first version of its next generati (...) Read the full story
MetaboGens medgrundare Fredrik Bäckhed har tilldelats the Minkowski Award på EASD.
– Det är väldigt hedrande att få det hä (...) Read the full story
On April 6, 2018, BioGaia became the majority shareholder in MetaboGen with a
62 percent stake. BioGaia has now, after the set mile (...) Read the full story
On April 6 2018, BioGaia announced its decision to acquire additional shares in MetaboGen and is now investing SEK 11.7 million in shares (...) Read the full story
MetaboGen AB has on January 30th, 2018 been granted a US patent for the identification of a person at risk for developing type 2 diabetes (...) Read the full story
Just nu pågår en forskningsstudie i Skåne och Stockholm för att undersöka bakgrunden till graviditetsklåda och om bakteriefloran i (...) Read the full story
Today, MetaboGen and BioGaia have agreed to initiate a new development program addressing restoration of the microbiome after antibiotic (...) Read the full story
Web of Science has just published its list of the world’s most-cited researchers. The list includes, for the third year in a row, Metab (...) Read the full story